EFFICACY AND SAFETY OF VALSARTAN IN HYPERTENSIVE CHILDREN 6 MONTHS TO 5 YEARS OF AGE: A RANDOMIZED, DOUBLE-BLIND, DOSE-RESPONSE STUDY

被引：1
|
作者：
Schaefer, F. [1 ]
Coppo, R. [2 ]
Kadwa, M. Y. [3 ]
Schlosshauer, R. [3 ]
Zhang, Y. [4 ]
机构：
[1] Univ Heidelberg Hosp, Div Pediat Nephrol, Ctr Pediat & Adolescent Med, Neuenheimer Feld, Germany
[2] Osped Regina Margherita Struttura Complessa Nefro, Turin, Italy
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
10.1097/01.hjh.0000379624.33658.75
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E473 / E473
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of valsartan in hypertensive children 6 months to 5 years of age
    Schaefer, Franz
    Coppo, Rosanna
    Bagga, Arvind
    Senguttuvan, Prabha
    Schlosshauer, Rolf
    Zhang, Ying
    Kadwa, Mahomed
    JOURNAL OF HYPERTENSION, 2013, 31 (05) : 993 - 1000
  • [2] A double-blind, dose-response study of losartan in hypertensive children
    Shahinfar, S
    Cano, F
    Soffer, BA
    Ahmed, T
    Santoro, EP
    Zhang, ZX
    Gleim, G
    Miller, K
    Vogt, B
    Blumer, J
    Briazgounov, I
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (02) : 183 - 190
  • [3] The Efficacy and Safety of the Novel Aldosterone Antagonist Eplerenone in Children with Hypertension: A Randomized, Double-Blind, Dose-Response Study
    Li, Jennifer S.
    Flynn, Joseph T.
    Portman, Ronald
    Davis, Ira
    Ogawa, Masayo
    Shi, Harry
    Pressler, Milton L.
    JOURNAL OF PEDIATRICS, 2010, 157 (02): : 282 - 287
  • [4] A 12-WEEK, RANDOMIZED, DOUBLE-BLIND STUDY COMPARING THE EFFICACY AND SAFETY OF VALSARTAN AND ENALAPRIL IN HYPERTENSIVE CHILDREN AGED 6-17 YEARS
    Schaefer, F.
    Litwin, M.
    Zachwieja, J.
    Boolell, M.
    Grosso, A.
    Pezous, N.
    JOURNAL OF HYPERTENSION, 2010, 28
  • [5] A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension
    Hazan, Lydie
    Hernandez Rodriguez, Oscar A.
    Bhorat, As'ad E.
    Miyazaki, Koichi
    Tao, Ben
    Heyrman, Reinilde
    HYPERTENSION, 2010, 55 (06) : 1323 - U70
  • [6] Repaglinide: A double-blind, randomized, dose-response study.
    Hedberg, TG
    Huang, WC
    DIABETOLOGIA, 1998, 41 : A235 - A235
  • [7] Dose-response efficacy of paroxetine in preventing depressive recurrences: A randomized, double-blind study
    Franchini, L
    Gasperini, M
    Perez, J
    Smeraldi, E
    Zanardi, R
    JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (05) : 229 - 232
  • [8] Dose-response study of the efficacy and safety of fosinopril in children with hypertension: A randomized, double-blind, placebo-controlled, multicenter clinical trial
    Li, JS
    Berezny, KY
    Kilaru, R
    Hazen, L
    Portman, R
    Hogg, R
    Jenkins, R
    Kanani, P
    Cottril, CM
    Mattoo, TK
    Zharkova, L
    Kozlova, L
    Weisman, I
    Deitchman, D
    Califf, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 482A - 482A
  • [9] Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study
    Schaefer, Franz
    Litwin, Mieczyslaw
    Zachwieja, Jacek
    Zurowska, Aleksandra
    Turi, Sandor
    Grosso, Amie
    Pezous, Nicole
    Kadwa, Mahomed
    JOURNAL OF HYPERTENSION, 2011, 29 (12) : 2484 - 2490
  • [10] A randomized, double-blind, placebo-controlled, dose-response efficacy and safety study of paliperidone palmitate in adults with schizophrenia
    Pandina, G.
    Lindenmayer, J. -P.
    Lull, J.
    Lim, P.
    Gopal, S.
    Herben, V.
    Kusumakar, V.
    Yuen, E.
    Palumbo, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 232 - 232
12345